BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 22540523)

  • 1. Does nutritional education improve the risk factors for cardiovascular diseases among elderly patients with type 2 diabetes? A randomized controlled trial based on an educational model.
    Sharifirad G; Najimi A; Hassanzadeh A; Azadbakht L
    J Diabetes; 2013 Jun; 5(2):157-62. PubMed ID: 22540523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.
    Querton L; Buysschaert M; Hermans MP
    J Clin Lipidol; 2012; 6(5):434-42. PubMed ID: 23009779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term (18-month) efficacy of atorvastatin therapy in type 2 diabetics at cardiovascular risk.
    Velussi M
    Nutr Metab Cardiovasc Dis; 2002 Feb; 12(1):29-35. PubMed ID: 12125227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-grain ready-to-eat oat cereal, as part of a dietary program for weight loss, reduces low-density lipoprotein cholesterol in adults with overweight and obesity more than a dietary program including low-fiber control foods.
    Maki KC; Beiseigel JM; Jonnalagadda SS; Gugger CK; Reeves MS; Farmer MV; Kaden VN; Rains TM
    J Am Diet Assoc; 2010 Feb; 110(2):205-14. PubMed ID: 20102847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Favorable effects on metabolic risk factors with daily brewer's yeast in type 2 diabetic patients with hypercholesterolemia: a semi-experimental study.
    Khosravi-Boroujeni H; Rostami A; Ravanshad S; Esmaillzadeh A
    J Diabetes; 2012 Jun; 4(2):153-8. PubMed ID: 22018047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular risk factors in obese women and their first-degree relatives.
    Saraç F; Ozgen AG; Yilmaz C; Tüzün M
    Anadolu Kardiyol Derg; 2007 Dec; 7(4):371-7. PubMed ID: 18065331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nutritional management of cardiovascular risk factors. A randomized clinical trial.
    McCarron DA; Oparil S; Chait A; Haynes RB; Kris-Etherton P; Stern JS; Resnick LM; Clark S; Morris CD; Hatton DC; Metz JA; McMahon M; Holcomb S; Snyder GW; Pi-Sunyer FX
    Arch Intern Med; 1997 Jan; 157(2):169-77. PubMed ID: 9009974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body adiposity index and other indexes of body composition in the SAPHIR study: association with cardiovascular risk factors.
    Melmer A; Lamina C; Tschoner A; Ress C; Kaser S; Laimer M; Sandhofer A; Paulweber B; Ebenbichler CF
    Obesity (Silver Spring); 2013 Apr; 21(4):775-81. PubMed ID: 23712981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triglyceride-to-HDL-cholesterol ratio and metabolic syndrome as contributors to cardiovascular risk in overweight patients.
    Marotta T; Russo BF; Ferrara LA
    Obesity (Silver Spring); 2010 Aug; 18(8):1608-13. PubMed ID: 20019684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Web-based targeted nutrition counselling and social support for patients at increased cardiovascular risk in general practice: randomized controlled trial.
    Verheijden M; Bakx JC; Akkermans R; van den Hoogen H; Godwin NM; Rosser W; van Staveren W; van Weel C
    J Med Internet Res; 2004 Dec; 6(4):e44. PubMed ID: 15631968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of low-density lipoprotein particle number in patients with type 2 diabetes mellitus and low-density lipoprotein cholesterol <100 mg/dl.
    Cromwell WC; Otvos JD
    Am J Cardiol; 2006 Dec; 98(12):1599-602. PubMed ID: 17145217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesterol lipoproteins, triglycerides, rural-urban differences and prevalence of dyslipidaemia among males in Rajasthan.
    Gupta R; Prakash H; Kaul V
    J Assoc Physicians India; 1997 Apr; 45(4):275-9. PubMed ID: 12521083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of low-density lipoprotein particle number distribution in patients with type 2 diabetes mellitus with low-density lipoprotein cholesterol <50 mg/dl and non-high-density lipoprotein cholesterol <80 mg/dl.
    Malave H; Castro M; Burkle J; Voros S; Dayspring T; Honigberg R; Pourfarzib R
    Am J Cardiol; 2012 Sep; 110(5):662-5. PubMed ID: 22621796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Women show worse control of type 2 diabetes and cardiovascular disease risk factors than men: results from the MIND.IT Study Group of the Italian Society of Diabetology.
    Franzini L; Ardigò D; Cavalot F; Miccoli R; Rivellese AA; Trovati M; Zavaroni I; Vaccaro O
    Nutr Metab Cardiovasc Dis; 2013 Mar; 23(3):235-41. PubMed ID: 22397873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a classroom-based weight-control intervention on cardiovascular disease in elementary-school obese children.
    Huang SH; Weng KP; Hsieh KS; Ou SF; Lin CC; Chien KJ; Liu PY; Ho TY
    Acta Paediatr Taiwan; 2007; 48(4):201-6. PubMed ID: 18265541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of dyslipidemia with waist to height ratio, waist circumference, and body mass index in Iranian adults.
    Chehrei A; Sadrnia S; Keshteli AH; Daneshmand MA; Rezaei J
    Asia Pac J Clin Nutr; 2007; 16(2):248-53. PubMed ID: 17468079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient knowledge of coronary risk profile improves the effectiveness of dyslipidemia therapy: the CHECK-UP study: a randomized controlled trial.
    Grover SA; Lowensteyn I; Joseph L; Kaouache M; Marchand S; Coupal L; Boudreau G;
    Arch Intern Med; 2007 Nov; 167(21):2296-303. PubMed ID: 18039987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic effects of low LDL cholesterol with other factors for the risk of cancer in type 2 diabetes: the Hong Kong Diabetes Registry.
    Yang X; So WY; Ma RC; Kong AP; Lee HM; Xu G; Ozaki R; Chan JC
    Acta Diabetol; 2012 Dec; 49 Suppl 1():S185-93. PubMed ID: 22722949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial epidemiological surveys in an urban Indian population demonstrate increasing coronary risk factors among the lower socioeconomic strata.
    Gupta R; Gupta VP; Sarna M; Prakash H; Rastogi S; Gupta KD
    J Assoc Physicians India; 2003 May; 51():470-7. PubMed ID: 12974428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.